Articles from SCHOTT Pharma

SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs – from biologics and other complex injectable therapies to vaccines and emergency room medications. The new capabilities feature state-of-the-art technology for efficient manufacturing and optimized output. The over 60 million USD investment was largely funded by the Biomedical Advanced Research and Development Authority (BARDA) to strengthen the resilience of the U.S. pharmaceutical supply chain and ensure reliable domestic production of critical primary packaging. The expansion significantly increases the site’s annual production capacity for core vials, while more than tripling local capacity for high-value solutions.